Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease

J Cancer Res Clin Oncol. 2023 Aug;149(10):6917-6929. doi: 10.1007/s00432-023-04650-0. Epub 2023 Feb 24.

Abstract

Purpose: Esophageal adenocarcinoma (EAC) remains a challenging and lethal cancer entity. A promising target for new therapeutic approaches, as demonstrated by the success of immune checkpoint inhibitors, are tumor-associated immune cells and the tumor microenvironment (TME). However, the understanding of the TME in esophageal cancer remains limited and requires further investigation.

Methods: Over 900 EAC samples were included, including patients treated with primary surgery and neoadjuvant (radio-)chemotherapy. The immune cell infiltrates of mast cells (MC), natural killer cells (NK cells), plasma cells (PC), and eosinophilic cells (EC) were assessed semi-quantitatively and correlated with histopathological parameters and overall survival (OS).

Results: A high presence of all four immune cell types significantly correlated with a less extensive tumor stage and a lower frequency of lymph node metastasis, and, in case of NK cells, with less distant metastasis. The presence of MC and NK cells was favorably associated with a prolonged OS in the total cohort (MC: p < 0.001; NK cells: p = 0.004) and patients without neoadjuvant treatment (MC: p < 0.001; NK cells: p = 0.01). NK cells were a favorable prognostic factor in the total cohort (p = 0.007) and in the treatment-naïve subgroup (p = 0.04). Additionally, MC were a favorable prognostic factor in patients with lymph node metastasis (p = 0.009).

Conclusion: Our results indicate a complex and important role of mast cells, NK cells, and the other assessed immune cells in the tumor microenvironment of EAC. Therefore, they are one further step to a better understanding of the immune cell environment and the potential therapeutic implications in this cancer entity.

Keywords: Esophageal adenocarcinoma; Esophageal cancer; Mast cells; Natural killer cells; Tumor immune environment; Tumor microenvironment.

MeSH terms

  • Adenocarcinoma* / pathology
  • Esophageal Neoplasms* / pathology
  • Humans
  • Killer Cells, Natural
  • Lymphatic Metastasis / pathology
  • Mast Cells / metabolism
  • Mast Cells / pathology
  • Prognosis
  • Tumor Microenvironment

Supplementary concepts

  • Adenocarcinoma Of Esophagus